SCHEMBL950861

SCHEMBL950861

Cc1c[nH]nc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL19384655 0.98 NOTUM (0.40)
Biphenyl SCHEMBL27658278 0.89 PIN1 (0.47)
SCHEMBL15195597 0.82
SCHEMBL19384586 0.80
SCHEMBL169065 0.80
SCHEMBL5761874 0.78 NPSR1 (0.48)
SCHEMBL15186359 0.77 YTHDC1 (0.42)
SCHEMBL1559800 0.77 MAP4K1 (0.38)
SCHEMBL16209016 0.76 KDM4E (0.36)
SCHEMBL719025 0.75 KDM4E (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492193-B2 Pyrazole derivatives for the treatment of cystic fibrosis FONDAZIONE INSTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-12-09 US claimed
US-20230212157-A1 PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS ISTITUTO GIANNINA GASLINI (IT) 2023-07-06 US claimed
US-11597723-B2 Pyrazole derivatives for the treatment of cystic fibrosis FONDAZIONE ISTITUTO ITALIANO DI TECHNOLOGIA (IT) 2023-03-07 US claimed
US-20150158749-A1 SELECTIVE EXTRACTION OF ANIONS FROM SOLUTION THE BOARD OF TRUSTEES OF WESTERN MICHIGAN UNIVERSITY 2015-06-11 US claimed
CN-101302200-B Preparation of N-piperidine subbase-5-(4-chlorphenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-formamide SHANGHAI INST PHARM INDUSTRY 2011-04-20 CN claimed
CN-1047775-C Substituted N-piperidino-pyrazole-3-carboxamide SANOFI SA (FR) 1999-12-29 CN claimed
CN-1110968-A Substituted N-piperidino-pyrazole-3-carboxamide SANOFI SA (FR) 1995-11-01 CN claimed
US-12492193-B2 Pyrazole derivatives for the treatment of cystic fibrosis FONDAZIONE INSTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-12-09 US disclosed
CN-119039225-A Purification method of fluorine-containing methyl pyrazole carboxylic ester 中蓝晨光化工研究设计院有限公司 2024-11-29 CN disclosed
CN-118541371-A Methionine adenosyltransferase 2A inhibitors for the treatment of MTAP deleted cancers 勤浩医药(苏州)有限公司 2024-08-23 CN disclosed
EP-4413004-A1 MACROCYCLIC COMPOUNDS HAVING ENT1 INHIBITING ACTIVITY iTeos Belgium SA (BE) 2024-08-14 EP disclosed
US-20230391752-A1 PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES CHULALONGKORN UNIVERSITY (TH) 2023-12-07 US disclosed
CN-116547275-A IL-17A modulators 赛诺菲 2023-08-04 CN disclosed
CN-1582278-A Polymorphous form of rimonabant, process for its preparation and pharmaceutical compositions containing it SANOFI SYNTHELABO (FR) 2005-02-16 CN disclosed
EP-1444210-A1 QUNAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2004-08-11 EP disclosed
WO-2004058702-A2 4-[(4-(CARBOXYETHYL) PIPERIDINYL) METHYL] PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2004-07-15 WO disclosed
WO-2004058763-A1 4(SPIROPIPERIDINYL)METHYL SUBSTITUTED PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2004-07-15 WO disclosed
WO-2003040108-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2003-05-15 WO disclosed
CN-1047775-C Substituted N-piperidino-pyrazole-3-carboxamide SANOFI SA (FR) 1999-12-29 CN disclosed
CN-1110968-A Substituted N-piperidino-pyrazole-3-carboxamide SANOFI SA (FR) 1995-11-01 CN disclosed